Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125.

Abstract

Monthly serum CA 125 determinations were used for monitoring of 33 patients with advanced nonmucinous epithelial ovarian cancer during the follow-up after the primary treatment. The observation time ranged between 3 and 7 years. All patients had elevated CA 125 levels at the start of chemotherapy with subsequent normalization during treatment. Seventeen… (More)

Topics

  • Presentations referencing similar topics